Does OBINUTUZUMAB Cause Multiple organ dysfunction syndrome? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Multiple organ dysfunction syndrome have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.4% of all adverse event reports for OBINUTUZUMAB.
57
Reports of Multiple organ dysfunction syndrome with OBINUTUZUMAB
0.4%
of all OBINUTUZUMAB reports
47
Deaths
30
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From OBINUTUZUMAB?
Of the 57 reports, 47 (82.5%) resulted in death, 30 (52.6%) required hospitalization, and 13 (22.8%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which OBINUTUZUMAB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE